Internal Medicine · Palm Springs, CA
NPI
1275632887
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1180 N Indian Canyon Dr, Ste E-317
Palm Springs, CA, 92262
Phone (760) 778-7147
Groups this clinician bills Medicare through
Medicare paid, 2024
$293K
16,675 services
Medicare patients, 2024
527
Average age 72
Drug cost, 2024
$2.3M
13,053 prescriptions
Company payments, 2025
$2,276
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dimple Agarwal was code 95165 (treatment - miscellaneous), 4,890 times for 20 patients. In total Dimple Agarwal billed 16,675 services in 57 codes, and Medicare paid $293K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 4,890 | 20 | $11.54 | $56K |
| 99214 Office E&M - Established | Office | 551 | 175 | $96.73 | $53K |
| 99233 Hospital E&M - Subsequent | Facility | 471 | 205 | $91.40 | $43K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 395 | 150 | $12.50 | $4,936 |
| 99215 Office E&M - Established | Office | 289 | 146 | $120.27 | $35K |
| 99239 Hospital Discharge Management | Facility | 170 | 164 | $87.80 | $15K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 121 | 121 | $129.44 | $16K |
| 99223 Hospital E&M - Initial | Facility | 112 | 108 | $134.12 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 105 | 45 | $61.61 | $6,469 |
| 96372 Injection Administration | Office | 98 | 28 | $11.22 | $1,100 |
| 99497 Care Management/Coordination | Office | 93 | 87 | $61.94 | $5,760 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 90 | 90 | $19.05 | $1,715 |
| 99497 Care Management/Coordination | Facility | 87 | 58 | $59.65 | $5,190 |
| 99213 Office E&M - Established | Office | 49 | 43 | $61.20 | $2,999 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 35 | 27 | $217.68 | $7,619 |
By year: 2022 $200K for 1,738 services; 2023 $446K for 20,665 services; 2024 $293K for 16,675 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87426 Immunoassay | 14 | 12 | $35.23 | $493 |
Medicare prescription drug claims, 2024
In 2024, the drug Dimple Agarwal prescribed most often to Medicare patients was Atorvastatin Calcium, with 720 prescriptions and refills. In total Dimple Agarwal wrote 13,053 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 720 | 1,750 | 243 | $6,991 |
| Amlodipine Besylate Generic | 631 | 1,509 | 213 | $3,650 |
| Levothyroxine Sodium Generic | 411 | 935 | 125 | $4,935 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 362 | 363 | 78 | $5,866 |
| Lisinopril Generic | 346 | 778 | 108 | $1,824 |
| Metoprolol Succinate Generic | 325 | 748 | 113 | $4,175 |
| Pantoprazole Sodium Generic | 320 | 635 | 103 | $3,287 |
| Metformin Hcl Generic | 315 | 786 | 121 | $2,154 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 311 | 453 | 100 | $17K |
| Ozempic Semaglutide | 290 | 425 | 77 | $383K |
| Rosuvastatin Calcium Generic | 266 | 634 | 99 | $4,289 |
| Gabapentin Generic | 265 | 521 | 88 | $3,871 |
| Losartan Potassium Generic | 250 | 595 | 93 | $2,015 |
| Trazodone Hcl Generic | 215 | 423 | 73 | $2,084 |
| Clonidine Generic | 193 | 386 | 60 | $30K |
Brand drugs: 2,517 claims; generic drugs: 10,420 claims; opioid claims: 589.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dimple Agarwal $2,276 ($2,276 in general payments such as food, travel and fees) from 25 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $394.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $394 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $201 |
| Amgen Inc. AMGN | 15 | $180 |
| Novo Nordisk Inc NVO | 10 | $164 |
| Viatris Specialty LLC | 10 | $138 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $125 |
| Lilly USA, LLC LLY | 6 | $124 |
| Axsome Therapeutics, Inc. AXSM | 1 | $122 |
| Baxter Healthcare BAX | 4 | $100 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $96.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.